SMTL ID : 7t39.1

Co-crystal structure of human PRMT9 in complex with MT221 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.81 Å

Oligo State

monomer

Ligands

1 x EJB: 7-[5-S-(4-{[(2-ethylpyridin-3-yl)methyl]amino}butyl)-5-thio-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine(Non-covalent)

EJB.1: 24 residues within 4Å: Chain A: E.25, W.27, H.28, M.31, I.59, G.60, C.81, E.82, L.83, T.109, K.110, S.111, E.130, T.131, V.132, D.133, A.134, E.139, S.144, F.287, T.299, C.306, W.307, E.308 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.27, A:W.27, A:T.131, A:E.139, A:F.287, A:T.299, A:W.307 Hydrogen bonds: A:G.60, A:L.83, A:S.111, A:S.111, A:S.144, A:E.308 pi-Stacking: A:W.307

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zeng, H. et al., Co-crystal structure of human PRMT9 in complex with MT221 inhibitor. To Be Published

Release Date

2021-12-22

Peptides

Protein arginine N-methyltransferase 9: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Protein arginine N-methyltransferase 9

Related Entries With Identical Sequence